Vision Essentials
Vision Essentials, licence 80042124: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Preferred Nutrition Inc.
- NPN or DIN-HM
- 80042124
- Status
- Inactive licence
- Licence date
- 6 May 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Cuivre: up to 4,000 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-alpha-acétamido-bêta-mercaptopropionique | 65.0 mg | Not calculated |
| Cuivre Source : Copper HVP chelate | 1.0 mg | 4,000 µg |
| Daucus carota Source : Racine | 65.0 mg | Not calculated |
| (3,7,12,16-Tétraméthyl-1,3,5,7,9,11,13,15,17-octadécanonaene-1,18-diyl)bis[2,6,6-triméthylcyclohexène]totalement E Potency : 3750.0 UI | 2250.0 mcg | Not calculated |
| Acide DL-alpha-lipoïque | 2.5 mg | Not calculated |
| Zinc Source : Monométhionine de Zinc | 12.5 mg | 50,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Eau purifiée, Gélatine, Cellulose microcristalline, Extrait de cassis, Quercétine, Glycine, Acide L-glutamique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
A factor in the maintenance of good health. Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps to produce and repair connective tissue. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to maintain healthy skin. Helps to maintain immune function. Helps to form red blood cells. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Helps to enhance cognitive function in adults. Helps to support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042124
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.